WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), is presenting at BioFuture 2023 on Thursday 2:45 PM, Oct 5th, at Lotte New York Palace hotel. This year, registered, in-person attendees can view MTTI's presentation live, and get advance access to a recorded version beginning September 1, five weeks prior to the actual event. Jianwei Xu, PhD, Chief Business Officer will introduce MTTI's EvaThera, the first long-acting, targeted peptide receptor radionuclide ther
